Lanreotide

Somatuline Autogel

Inj 120 mg per 0.5 ml, 0.5 ml syringeNew ZealandFunded

In other countries

The same active substances on other registers, the same brand first.

Somatuline AutogelBrazil · Beaufour Ipsen Farmacêutica LtdaSame brand
Somatuline AutogelBrazil · Biosintética Farmacêutica LtdaSame brand
Somatuline AutogelCanada · 60 MG / SYR · Solution (Extended-Release) · Ipsen Biopharmaceuticals Canada INCSame brand
Somatuline AutogelCanada · 120 MG / SYR · Solution (Extended-Release) · Ipsen Biopharmaceuticals Canada INCSame brand
Somatuline AutogelCanada · 90 MG / SYR · Solution (Extended-Release) · Ipsen Biopharmaceuticals Canada INCSame brand
Somatuline AutoSolution 120 mg, oplossing voor injectie in een voorgevulde spuitNetherlands · Oplossing voor injectie · Medcor Pharmaceuticals B.V.Same brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Lanreotide

Somatuline Autogel

Inj 120 mg per 0.5 ml, 0.5 ml syringeNew ZealandFunded

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Somatuline AutoSolution 120 mg, oplossing voor injectie in een voorgevulde spuitNetherlands · Oplossing voor injectie · Euro Registratie Collectief B.V.

Somatuline AutoSolution 120 mg, oplossing voor injectie in een voorgevulde spuitNetherlands · Oplossing voor injectie · BModesto B.V.

SOMATULINE AUTOGEL 120 mgRomania · 120mg · sol. inj. in seringa preumpluta · Ipsen Pharma

SOMATULINE PR 30 mgRomania · 30mg · pulb+solv. pt. susp. inj. cu elib.prel. · Ipsen Pharma

Somatuline® Autogel®Serbia · 120mg · rastvor za injekciju u napunjenom injekcionom špricu · Pharmaswiss D.O.O., Beograd

Somatuline® Autogel®Serbia · 60mg · rastvor za injekciju u napunjenom injekcionom špricu · Pharmaswiss D.O.O., Beograd

Somatuline® Autogel®Serbia · 90mg · rastvor za injekciju u napunjenom injekcionom špricu · Pharmaswiss D.O.O., Beograd

Somatuline Autogel 120 MG Solution for Injection in Pre-FilleSaudi Arabia · Ipsen Pharma Biotech

Somatuline Autogel 60 MG Solution for Injection in Pre-FilleSaudi Arabia · Ipsen Pharma Biotech

Somatuline Autogel 90 MG Solution for Injection in Pre-FilleSaudi Arabia · Ipsen Pharma Biotech

Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 120 mgSingapore · 120 mg · injection, solution · Ipsen Pharma Singapore Pte. LTD.

Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 60 mgSingapore · 60 mg · injection, solution · Ipsen Pharma Singapore Pte. LTD.

Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 90 mgSingapore · 90 mg · injection, solution · Ipsen Pharma Singapore Pte. LTD.

Somatuline DepotUnited States · 120MG BASE/0.5ML, 60MG BASE/0.2ML, 90MG BASE/0.3ML · solution · Ipsen Pharma

Myrelez 120 MG Solucion Inyectable en Jeringa Precargada EfgSpain · 133,33 mg · solución inyectable en jeringa precargada · Amdipharm Limited

Myrelez 60 MG Solucion Inyectable en Jeringa Precargada EfgSpain · 66,67 mg · solución inyectable en jeringa precargada · Amdipharm Limited

Myrelez 90 MG Solucion Inyectable en Jeringa Precargada EfgSpain · 100 mg · solución inyectable en jeringa precargada · Amdipharm Limited

IpstylItaly · Soluzione iniettabile · Ipsen S.P.A

LanrenetItaly · Soluzione iniettabile in siringa pre-riempita · Mylan S.P.A.

Lanreotide SunItaly · Soluzione iniettabile in siringa pre-riempita · Sun Pharmaceutical Industries (Europe) B.V.

Lanreotide AcetateUnited States · 120MG BASE/0.5ML, 60MG BASE/0.2ML, 90MG BASE/0.3ML · solution · Invagen Pharms

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

PHARMAC, New Zealand

New Zealand Pharmaceutical Management Agency (PHARMAC); https://schedule.pharmac.govt.nz/pub/schedule/archive/Schedule_2026-10.xml; October 2026; published 2026-10-08; acquired 2026-10-13T22:49:29.739475+00:00. XML-to-graph and conservative medicine-domain projections are adaptations. Written attribution; PHARMAC logo excluded.

Licence: CC BY 4.0; PHARMAC Pharmaceutical Schedule XML files · Added 14 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Lanreotide
Dosage form: Inj 120 mg per 0.5 ml, 0.5 ml syringe
Register: New Zealand (PHARMAC)
Status: Funded
Status in the register: Funded by PHARMAC
Procedure: Community Pharmaceutical Schedule
Supply: Funded (PHARMAC)

PHARMAC

MytolacLanreotide · Inj 120 mg per 0.5 ml, 0.5 ml syringeNew Zealand

Mytolac S29Lanreotide · Inj 60 mg per 0.5 ml, 0.5 ml syringeNew Zealand

Somatuline AutogelLanreotide · Inj 60 mg per 0.5 ml, 0.5 ml syringeNew Zealand

Somatuline AutogelLanreotide · Inj 90 mg per 0.5 ml, 0.5 ml syringeNew Zealand